These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 8060
21. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism. Chen Y, Cheng D, Tio C, Kagan N, Eisennagel S, Dasgupta M, Tomczuk B, Bone R, Huebert N. Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144 [Abstract] [Full Text] [Related]
22. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA. Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [Abstract] [Full Text] [Related]
23. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine. Ahr HJ, Krause HP, Siefert HM, Suwelack D, Weber H. Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402 [Abstract] [Full Text] [Related]
25. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Hucker HB, Stauffer SC, White SD, Rhodes RE, Arison BH, Umbenhauer ER, Bower RJ, McMahon FG. Drug Metab Dispos; 1973 Aug; 1(6):721-36. PubMed ID: 4156293 [No Abstract] [Full Text] [Related]
26. Species and gender differences in the formation of an active metabolite of a substituted 2,4-thiazolidinedione insulin sensitizer. Beconi M, Mao A, Creighton M, Hop CE, Chiu SH, Eydelloth R, Franklin R, Tang F, Yu N, Vincent S. Xenobiotica; 2003 Jul; 33(7):767-87. PubMed ID: 12893525 [Abstract] [Full Text] [Related]
27. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey. Maruhn D, Siefert HM, Weber H, Rämsch K, Suwelack D. Arzneimittelforschung; 1985 Jul; 35(12):1781-6. PubMed ID: 4096729 [Abstract] [Full Text] [Related]
28. The comparative metabolism of zolazepam in rat, dog and monkey. Baukema J, Okerholm RA, Glazko AJ. Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):227-38. PubMed ID: 808840 [Abstract] [Full Text] [Related]
29. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans. Scatina JA, Wells DS, Kimmel HB, Kemper CJ, Sisenwine SF. Drug Metab Dispos; 1990 Feb; 18(5):746-52. PubMed ID: 1981731 [Abstract] [Full Text] [Related]
30. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence. Lin JH, Chiba M, Chen IW, Nishime JA, Vastag KJ. Drug Metab Dispos; 1996 Dec; 24(12):1298-306. PubMed ID: 8971134 [Abstract] [Full Text] [Related]
31. Metabolic disposition of isoxicam in man, monkey, dog, and rat. Borondy PE, Michniewicz BM. Drug Metab Dispos; 1984 Dec; 12(4):444-51. PubMed ID: 6148211 [Abstract] [Full Text] [Related]
32. Metabolism of labetalol by animals and man. Martin LE, Hopkins R, Bland R. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152 [Abstract] [Full Text] [Related]
33. Metabolic fate of [14C]-brotizolam in the rat, dog, monkey and man. Bechtel WD, Mierau J, Brandt K, Förster HJ, Pook KH. Arzneimittelforschung; 1986 Mar; 36(3A):578-86. PubMed ID: 3718581 [Abstract] [Full Text] [Related]
34. Investigations of the analgesic and morphine-like properties of azidomorphine. Hill RC, Roemer D, Buescher H. J Pharmacol Exp Ther; 1977 Jun; 201(3):580-6. PubMed ID: 405472 [Abstract] [Full Text] [Related]
35. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys. Vincent SH, Painter SK, Luffer-Atlas D, Karanam BV, McGowan E, Cioffe C, Doss G, Chiu SH. Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401 [Abstract] [Full Text] [Related]
36. In vitro hydrolysis of RR,SS-threo-methylphenidate by blood esterases--differential and enantioselective interspecies variability. Srinivas NR, Hubbard JW, McKay G, Hawes EM, Midha KK. Chirality; 1991 Aug; 3(2):99-103. PubMed ID: 1863524 [Abstract] [Full Text] [Related]
37. Evaluation of succinimidoethyl and pivaloyloxyethyl esters as progenitors of methyldopa in man, rhesus monkey, dog, and rat. Vickers S, Duncan CA, White SD, Breault GO, Royds RB, de Schepper PJ, Tempero KF. Drug Metab Dispos; 1978 Aug; 6(6):640-6. PubMed ID: 33026 [Abstract] [Full Text] [Related]
38. Metabolic studies of 3 H-orphenadrine citrate in the rat, dog and rhesus monkey. Ellison T. Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):213-30. PubMed ID: 4622666 [No Abstract] [Full Text] [Related]
39. Metabolic disposition of ciramadol in rhesus monkeys and rats. Sisenwine SF, Tio CO, Ruelius HW. Drug Metab Dispos; 1982 Feb; 10(2):161-7. PubMed ID: 6124403 [Abstract] [Full Text] [Related]
40. Renal tubular transport of methotrexate in the rhesus monkey and dog. Huang KC, Wenczak BA, Liu YK. Cancer Res; 1979 Dec; 39(12):4843-8. PubMed ID: 115582 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]